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Subintimal Ki-67 as a synovial tissue biomarker for
inflammatory arthropathies
Abstract
OBJECTIVES: Ki-67 is expressed in the nuclei of dividing cells and can be used to assess proliferation
of synovial inflammatory and stromal cells. We evaluated subintimal Ki-67+ cell density as a tissue
biomarker for inflammatory arthropathies and compared it to subintimal CD68, a synovial biomarker of
RA. METHODS: Subintimal Ki-67+ and CD68+ cell densities were measured immunohistochemically
in synovial specimens obtained from patients with rheumatoid arthritis (RA; n = 19), osteoarthritis (OA;
n = 18), "non-inflammatory" orthopaedic arthropathies (avascular necrosis, meniscus injury, femur
fracture; n = 16), chronic septic arthritis (n = 9), and histologically normal synovium (n = 10).
RESULTS: were correlated with a histological synovitis score. Utilising the areas under receiver
operating characteristic curves (AUCs), we compared the abilities of Ki-67 and CD68 to differentiate
among these arthropathies. Results: Ki-67 was expressed widely in the subintimal of inflamed
specimens and in RA pannus invading hard tissues. Compared to normal controls, it was highly
overexpressed in RA (26.6-fold) and chronic septic arthritis (55-fold), and mildly elevated in OA
(3.9-fold) and orthopaedic arthropathies (2.1-fold). Ki-67 and CD68 differentiated similarly well
between RA and OA (AUC: Ki-67 = 0.91, CD68 = 0.94), Ki-67 better between chronic septic arthritis
and RA, and CD68 better between OA and normal controls. Ki-67 (r = 0.80) and CD68 (r = 0.79)
correlated positively with the synovitis score. CONCLUSIONS: Subintimal Ki-67 was overexpressed in
inflammatory arthropathies, distinguished among differentially inflamed arthropathies, and correlated
positively with the histological severity of synovitis. It may prove useful in synovial tissue classification
and as a synovial marker of disease activity in clinical trials when biopsies are available.
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ABSTRACT
Objectives: Ki-67 is expressed in the nuclei of dividing
cells and can be used to assess proliferation of synovial
inflammatory and stromal cells. We evaluated subintimal
Ki-67+ cell density as a tissue biomarker for inflammatory
arthropathies and compared it to subintimal CD68, a
synovial biomarker of RA.
Methods: Subintimal Ki-67+ and CD68+ cell densities
were measured immunohistochemically in synovial spe-
cimens obtained from patients with rheumatoid arthritis
(RA; n = 19), osteoarthritis (OA; n = 18), ‘‘non-inflam-
matory’’ orthopaedic arthropathies (avascular necrosis,
meniscus injury, femur fracture; n = 16), chronic septic
arthritis (n = 9), and histologically normal synovium
(n = 10). Results were correlated with a histological
synovitis score. Utilising the areas under receiver
operating characteristic curves (AUCs), we compared the
abilities of Ki-67 and CD68 to differentiate among these
arthropathies.
Results: Ki-67 was expressed widely in the subintima of
inflamed specimens and in RA pannus invading hard
tissues. Compared to normal controls, it was highly
overexpressed in RA (26.6-fold) and chronic septic
arthritis (55-fold), and mildly elevated in OA (3.9-fold) and
orthopaedic arthropathies (2.1-fold). Ki-67 and CD68
differentiated similarly well between RA and OA (AUC: Ki-
67 = 0.91, CD68 = 0.94), Ki-67 better between chronic
septic arthritis and RA, and CD68 better between OA and
normal controls. Ki-67 (r = 0.80) and CD68 (r = 0.79)
correlated positively with the synovitis score.
Conclusions: Subintimal Ki-67 was overexpressed in
inflammatory arthropathies, distinguished among differ-
entially inflamed arthropathies, and correlated positively
with the histological severity of synovitis. It may prove
useful in synovial tissue classification and as a synovial
marker of disease activity in clinical trials when biopsies
are available.
The nuclear antigen Ki-67 is closely associated with
cellular proliferation in that it is specifically
expressed in G1, S, G2, and M phases of the cell
cycle, but not in quiescent (G0) cells.
Ultrastructural studies have shown that it is a
critical component of the formation of the
perichromosomal scaffold and supports the
nucleoli during cell proliferation.1 Due to this close
association with cell division, Ki-67 is widely used
in tumour classification, but it has also been used
to characterise proliferating cells in diseased syno-
vium, namely in the hyperplastic synovial lining2–5
and in subintimal lymphocyte populations.2 6 7
A principal difference between Ki-67 and other
currently used histological synovial biomarkers (eg,
CD68 or CD38) lies in the fact that it may be
expressed by any dividing synovial cell and therefore
does not measure the numbers of a given cell type
but, rather, the activity of a tissue-wide process. Its
expression would therefore reflect proliferation of
resident stromal cells as well as of infiltrating
inflammatory cells. The exclusive nuclear localisation
of Ki-67 represents an added benefit for histomor-
phometric analyses in that it facilitates differentiat-
ing positive staining cells from negative staining
ones, even in densely packed cell clusters. Recently,
the search for synovial biomarkers of disease activity
and treatment response in inflammatory arthropa-
thies has focused on infiltrating inflammatory cells in
the synovial subintima.8 9 However, the potential of
subintimal Ki-67 as a tissue biomarker in terms of
disease activity and tissue diagnosis has not been
studied. In the present study, we have therefore
evaluated the potential of subintimal Ki-67 to
distinguish among various arthropathies and assessed
its correlation with disease activity as measured by
histological abnormalities of synovitis.
MATERIALS AND METHODS
Synovial tissue specimens were obtained by closed
needle biopsy or surgically at the time of arthro-
plasty. The following specimen groups were
studied: rheumatoid arthritis (RA) with active
disease despite disease modifying anti-rheumatic
drug (DMARD) treatment (n = 19), chronic septic
arthritis proven by positive bacterial culture (n = 9;
disease duration in these specimens was estimated
from retrospective chart review and was between
>4 weeks and 1 year), osteoarthritis (OA; n = 18),
and 16 specimens from orthopaedically-treated
arthropathies (OrthA, consisting of femur fracture
(n = 3), meniscus injury (n = 10), and avascular
necrosis of the femoral head (n = 3)) as ‘‘less
inflamed’’ disease controls. These orthopaedic
arthropathies form a heterogeneous group char-
acterised by mild synovitis, similar to that often
seen in OA.10 Ten histologically unremarkable
specimens from patients with non-inflammatory
knee pain11 were included as ‘‘normal’’ controls.
The absence of appreciable numbers of inflamma-
tory cells was verified in these ‘‘normal’’ specimens
by immunostaining for CD3, CD20, CD38 and
CD68. Expression at sites of pannus invading
cartilage and bone was determined in one RA
specimen obtained at the time of arthroplasty.
Tissues were fixed in formalin and embedded in
paraffin according to standard practice. Sections (5-
mm thick) were prepared on a microtome and
immunostained on an automated staining system
(Ventana Benchmark, Ventana, Tucson Arizona,
USA) for Ki-67 (clone K-2) or CD68 (Kp-1), using
pre-diluted commercial antibody preparations
(Ventana). General antigen preservation was tested
Extended report
162 Ann Rheum Dis 2008;67:162–167. doi:10.1136/ard.2007.071670
 on 5 August 2008 ard.bmj.comDownloaded from 
in all specimens by staining for von Willebrand Factor (vWF).
One specimen was excluded from the analysis because of lack of
vWF staining even though blood vessels were present, suggest-
ing poor antigen preservation. The numbers of Ki-67 or CD68
expressing cells per high power field (hpf, 4006) were
determined in 5-12 fields per specimen by manual cell counting
as described.11 Only fields with clearly recognisable lining and
subintimal vasculature were included. All results were con-
verted to densities per mm2 using the formula positive staining
cells/mm2 = (positive staining cells/4006 field)66.29.
Using the values for subintimal Ki-67+ or CD68+ cell
densities, the sensitivities and specificities of each marker in
differentiating between any two arthropathies were determined
for all available values. These were then plotted as receiver
operating characteristic curves (ROCs), where the area under
the curve (AUC) is a numeric measure of the ability of a
diagnostic test to distinguish between two diagnostic possibi-
lities.12 The AUCs and corresponding p values were calculated
with the SPSS biostatistical software (SPSS Inc., Chicago,
Illinois, USA). Using the grading system (‘‘synovitis score’’)
described by Krenn et al,13–15 the histopathological severity of
synovitis was determined in 37 specimens (RA, n = 14; OA,
n = 10; OrthA, n = 5; and ‘‘normal’’, n = 8) in which Ki-67 and
CD68 expression had been determined immunohistochemically.
These specimens were selected to encompass a broad range of
inflammation and to contain members of all specimen groups,
except chronic septic arthritis, for which this score has not been
validated. In order to account for the relatively small sizes of
some of the needle biopsies, the grading system was modified
insofar as the score for each specimen was derived from the
Figure 1 Representative
immunohistochemical findings.
Diaminobenzidine (brown; nearly black in
highly expressing nuclei) was used as
chromogen. SeA, chronic septic arthritis.
A and B. Diffusely infiltrating abundant Ki-
67+ cells in chronic septic arthritis. Ki-
67+ lymphoid follicles were also seen in
one of the specimens (not shown here).
C. RA. Classic lymphoid follicle with a Ki-
67+ germinal centre surrounded by a
transitional zone containing further Ki-67+
lymphocytes. Superficial subintima; the
lining is barely visible at the right margin
of the image. D. Ki-67+cells in a plasma
cell-rich infiltrate in an RA villus. A few Ki-
67+ cells are seen in the adjacent
hyperplastic lining (arrows). li, lining. E.
OA. A solitary Ki-67+ cell at the junction
between subintima and lining. F. OA. A
small number of Ki-67+ cells in the
subintima. G. Normal synovium. Ki-67+
adipocytes (some marked by arrows). H.
Normal synovium. An uncommon
example of Ki-67 expression in non-
adipocyte stromal cells (arrows).
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average of 3–10 microscopic fields (2006). Subintimal Ki-67 or
CD68 cell densities were correlated separately with the
synovitis score by linear regression. Statistical significance was
determined by analysis of variance (ANOVA), and sample size
calculation with the open access software program PS vs 2.1.31
(available at http://biostat.mc.vanderbilt.edu).
RESULTS
Immunohistochemical detection of Ki-67 in synovium and at the
pannus/hard tissue interface
Ki-67 was detected in all specimens with adequate antigen
preservation, as determined by vascular staining for vWF.
Consistent with previous reports,2–5 Ki-67 was expressed in
lining and subintima (fig 1). Ki-67+ cells were essentially absent
from the lining of normal controls (fig 1G,H) and were detected
rarely in the OA lining. Even though they were more common,
Ki-67 expressing cells were relatively sparse even in the
hyperplastic lining of RA (eg, fig 1D). In the subintima, Ki-67
appeared to be much more common in the inflamed specimens,
particularly in those obtained from patients with chronic septic
arthritis or RA (fig 1A–D). Highest concentrations were seen in
and near lymphoid aggregates, which were most common in
RA. Figure 1C illustrates a lymphoid follicle seen in an RA
specimen, with a cluster of Ki-67+ cells defining the germinal
centre. Figure 1D shows a different RA specimen, which
contained scattered Ki-67+ cells in a plasma cell-rich subintimal
infiltrate as well as positively staining foci in the hyperplastic
lining. Only solitary Ki-67+ cells typically occurred in OA
(fig 1E–F). Ki-67 was also detected in adipose tissue of
minimally inflamed and normal specimens, and adipocytes
often represented the only Ki-67+ cells in the normal controls
(fig 1G). These were excluded from the semi-quantitative
analysis. Whereas it did not seem to occur in chondrocytes,
Ki-67 was detected in cells at the leading front of RA pannus
invading surface cartilage (fig 2A) and, more frequently, in
vascularised pannus that had penetrated into subchondral bone
(fig 2B).
Semi-quantitative differences among the specimen groups in
subintimal Ki-67+ and CD68+ cell densities
We then determined the relative expression of subintimal Ki-67
and CD68 in the arthropathies included in this study (fig 3).
The x-fold expression differences and p values are summarised
in table 1. The mean Ki-67+ cell density was lower than the
mean CD68+ cell density in all specimen groups. The smallest
difference was seen in chronic septic arthritis, which contained
only 33% fewer Ki-67+ than CD68+ cells, and the largest in OA,
OrthA and normal controls (80–84% fewer Ki-67 cells). The
lowest mean Ki-67+ cell density occurred in the normal
specimens (fig 3). Mildly elevated mean densities were found
in OrthA and OA, and even higher values in RA. Notably, the
highest mean density was found in chronic septic arthritis,
resulting in a mean 55-fold overexpression compared to the
normal controls. CD68+ cell densities followed a similar trend,
except that there was no significant difference between RA and
SeA and that the differences between RA and SeA vs OA or
normals were smaller than those measured with Ki-67 (table 1).
Given the relatively small sample sizes in this study, a sample
size calculation was performed to determine minimal sample
sizes needed to differentiate RA from the other arthropathies.
With the exception of CD68 in the comparison RA vs SeA
(whose x-fold expression difference was marginal and not
statistically significant), the predicted sample sizes fell within
the sizes of the specimen groups used (table 2).
Subintimal Ki-67+ cell density in the differential histological
classification of synovitis
Based on the expression data summarised in fig 3, we then
computed sensitivities and specificities for all available Ki-67+ or
CD68+ cell densities in the differentiation between any two
arthropathies. The areas under the corresponding ROC curves
were used to compare the performance of Ki-67 and CD68 as
diagnostic markers (table 1, columns 5 and 6). Consistent with
the dramatic overexpression of both markers in RA and chronic
septic arthritis (fig 3 and table 1), they distinguished between
RA or chronic septic arthritis and the normal controls with the
maximally possible AUCs of 1. Both factors also had similar
AUCs for distinguishing between OA and RA and between OA
and chronic septic arthritis. However, they differed greatly in
the ability to differentiate between other specimen groups:
CD68 distinguished better between OA or OrthA and normal
controls, whereas Ki-67 differentiated better between chronic
septic arthritis and RA. Of note, the differences between Ki-67
and CD68 in AUCs did not always correspond to their x-fold
differences in positive staining cell densities. For example, in the
comparison chronic septic arthritis/OA, the x-fold increase of
Ki-67+ cell density in chronic septic arthritis (with respect to
OA) was 3.9-fold higher than that of CD68 (14.1 vs 3.6),
whereas their AUCs were nearly identical. Likewise, in the
comparison RA/OA, the x-fold increase in Ki-67+ and CD68+
cell densities was 1.8-fold higher than the increase in CD68 (6.8
vs 3.8), but its AUC was slightly lower (table 1).
Figure 2 Expression of Ki-67 in RA
pannus invading hard tissues. A. A small
number of Ki-67+ cells in pannus invading
surface cartilage. P, pannus; C, cartilage.
B. Higher density of Ki-67+ cells in
vascularised pannus invading subchondral
bone. The arrows point to Ki-67+ cells
located at the pannus/bone interface. B,
bone.
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Correlation of subintimal Ki-67+ cell density with the synovitis
score
Ki-67+ and CD68+ cell densities were compared to synovitis
scores in 37 specimens. Ki-67+ subintimal cell densities cor-
related strongly with the synovitis score (fig 4). Its correlation
coefficient (r) of 0.80 was essentially identical to that of CD68
(r = 0.79), a marker closely associated with RA in terms of
tissue diagnosis16 17 and clinical response to treatment.8 9 This
result substantiated further the close association of subintimal
Ki-67 expression, and therefore cell proliferation, with inflam-
matory arthropathies.
DISCUSSION
In this study, we have quantified further the association of
subintimal Ki-67 expression with synovitis, have begun to
evaluate its potential as a tissue biomarker and, notably, found
a strong correlation with the histological degree of synovitis.
Subintimal Ki-67+ cell densities have not been quantified
systematically in cohorts of differentially inflamed arthropa-
thies. The fundamental study by Nyka¨nen et al18 identified B
and T lymphocytes as major proliferating cell types in RA
synovium, a finding that was later confirmed by double
immunohistochemistry with lymphocyte surface markers and
Ki-67.2 To our knowledge, only one study, which focused on Ki-
67 expression in the synovial lining, attempted to identify
systematic differences among different arthropathies.4 These
authors showed that Ki-67 positive cells tended to be more
frequent in the lining of RA synovium than in reactive arthritis
or psoriatic arthritis, although these differences were not
statistically significant. Consistent with this trend toward
higher Ki-67 expression in RA, our present analysis of Ki-67
expression in the subintima revealed a remarkable, statistically
significant overexpression in RA, compared to the less inflamed
disease controls and normal specimens (figs 1 and 3; table 1).
The present study also demonstrates that, compared to
histologically normal synovium, subintimal Ki-67+ cell density
is increased in the less inflamed synovial specimens such as OA
and OrthA. This agrees with the notion that at least mild
inflammation occurs often in OA synovium. We have recently
shown that ‘‘non-inflammatory’’ orthopaedic arthropathies
form a heterogeneous group of mildly inflamed specimens,
similar to OA.10 This finding is supported by the current results
that the numbers of Ki-67+ cells were similar in OrthA and OA,
but higher in both than in the ‘‘normal’’ controls (fig 3).
Surprisingly, the highest mean Ki-67+ cell density was detected
in chronic septic arthritis. This is likely due to the presence of
Figure 3 Semi-quantitative differences in Ki-67 and CD68 expression.
Ki-67+ or CD68+ cell densities were determined by manual cell counting
in the following specimens: rheumatoid arthritis (RA; n = 19), chronic
septic arthritis (SeA; n = 9), osteoarthritis (OA; n = 18), ‘‘non-
inflammatory’’ orthopaedic arthropathies (OrthA; n = 16), and non-
inflammatory knee pain (‘‘normal’’; n = 10). Values correspond to
positive staining cells/mm2. Upper horizontal line, maximum value; lower
horizontal line, minimum value; upper edge of box, upper quartile; bottom
edge of box, lower quartile; horizontal bar inside box, median. A. Ki-67.
B. CD68.
Table 1 Ki-67 and CD68+ cell densities and AUCs* as diagnostic biomarkers in synovium
Comparison
x-Fold differences in positive staining cells/mm2 AUC
Ki-67 (p value) CD68 (p value) Ki-67 (p value) CD68 (p value)
OA vs normal 3.9 (0.028) 3.7 (0.003) 0.78 (0.014) 0.87 (0.002)
OrthA vs normal 2.1 (0.14) 2.5 (0.06) 0.61 (0.34) 0.74 (0.046)
RA vs normal 26.6 (,0.001) 13.9 (,0.001) 1 (,0.001) 1 (,0.001)
SeA{ vs normal 55.0 (,0.001) 13.4 (,0.001) 1 (,0.001) 1 (,0.001)
RA vs OA 6.8 (,0.001) 3.8 (,0.001) 0.91 (,0.001) 0.94 (,0.001)
SeA vs OA 14.1 (,0.001) 3.6 (,0.001) 1 (,0.001) 0.99 (,0.001)
SeA vs RA 2.1 (0.035) 0.96 (0.82) 0.79 (0.015) 0.49 (0.92)
*AUC, area under the curve; derived from the corresponding receiver operating characteristic (ROC) curves.
{SeA, chronic septic arthritis (disease duration 4 weeks to 1 year).
OA, osteoarthritis; OrthA, orthopaedically-treated arthropathies; RA, rheumatoid arthritis.
Table 2 Sample size calculation comparing Ki-67 and CD68*
RA vs SeA RA vs OA RA vs OrthA RA vs normal
Ki-67 9 7 5 4
CD68 1612 4 3 2
*Minimal sample sizes needed to achieve a ,0.05 and power .0.80.
OA, osteoarthritis; OrthA, orthopaedically-treated arthropathies; RA, rheumatoid
arthritis; SeA, chronic septic arthritis.
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dividing cells in the inflammatory infiltrates, such as lympho-
cytes, although we suspect that induction of the cell cycle in
resident fibroblasts and other stromal cells also contributes.
Furthermore, in a separate study we have detected significantly
increased vascular density in the synovium of chronic septic
arthritis, and have also demonstrated the presence of CD31/Ki-
67 double positive vascular endothelial cells, reflecting angio-
genesis.19 Thus, a portion of the subintimal Ki-67+ cells likely
also correspond to proliferating vascular endothelium. A
potentially clinically important implication of our results is
that in situations where culture results are not available, a high
density of Ki-67+ subintimal cells might raise a suspicion of
chronic septic arthritis.
ROC analysis has to our knowledge not previously been
applied to histomorphometric studies of synovium, but has
been used in the evaluation of diagnostic histological markers in
other tissues, such as tumours. In the present study, the ROC
analysis revealed instructive differences between Ki-67 and
CD68 in their abilities to differentiate between pairs of
arthropathies. Notably, only Ki-67 separated chronic septic
arthritis from RA, whereas CD68 distinguished better between
RA and OA. Interestingly, in some cases the relative differences
of the mean Ki-67+ or CD68+ cell densities in the arthropathy
pairs deviated from the respective AUC values. For example,
despite the large differences between the relative Ki-67+ and
CD68+ cell densities in the comparison chronic septic arthritis
vs OA, their AUC values were nearly identical (table 1). When
evaluating the importance of a factor or cell type histomorpho-
metrically, its x-fold overexpression compared to normal or
disease controls is often taken as a measure of its contribution
to pathogenesis or diagnosis. The present results suggest that
the use of AUCs would give different results in some cases. We
suggest that AUCs would reflect expression differences between
specimen groups more accurately because they also consider the
spread of the values within each group and the overlap in the
values of two groups. The relatively small numbers of speci-
mens in each group represent a shortcoming of the present
study. While our intriguing preliminary results demonstrate
that it is feasible to evaluate synovial tissue markers by ROC
curve analysis, they would need to be validated in future studies
with higher numbers of specimens. Moreover, for this study we
did not have access to synovial specimens from psoriatic or
reactive arthritis, both of which are sometimes difficult to
distinguish from RA. It would be equally interesting and
clinically important to evaluate the abilities of Ki-67 and CD68
to aid in the differential tissue diagnosis among these latter
three arthropathies.
The high numbers of Ki-67+ cells in the RA specimens agree
well with previous reports of increased cell division in RA
synovium and at the pannus–hard tissues interface.20–22
Subintimal Ki-67+ expression also correlated strongly with
histological alterations associated with synovitis, indicating that
it is pathogenetically relevant. For histopathologic grading, we
chose the scoring system by Krenn et al13–15 because of its broad
dynamic range, which allows for the detection of inflammation-
associated changes in high-grade synovitis, but also in the
mildly inflamed OA and OrthA specimens. The validity of this
scoring system in the present study was confirmed by the fact
that the mean synovitis scores of our RA and OA specimen
groups were very similar to those reported by Krenn et al.14 15 Ki-
67+ cells correlated nearly as strongly with the synovitis score as
CD68+ subintimal cells, a marker strongly associated with a
diagnosis of RA16 17 and currently the best validated synovial
marker for a positive response to pharmacologic treatment of
RA.8 9 Thus, Ki-67 promises to be useful as a marker for similar
clinical aspects of inflammatory arthropathies. It will now be
important to perform additional studies, which evaluate the
expression of Ki-67 in other inflammatory arthropathies such as
psoriatic and reactive arthritis, and its correlation with a
response to treatment interventions and other clinical out-
comes. The search for synovial biomarkers in OA has been
dissatisfying. Considering the correlation of Ki-67 with the
synovitis score in the lower part of the spectrum (fig 4) and its
small but significant overexpression in OA compared to normal
controls (fig 3), it also merits further investigation as a synovial
biomarker in less inflamed arthropathies such as OA.
Considering (1) the ease with which Ki-67+ cells can be
distinguished from Ki-67 negative cells, and (2) the large
expression differences obtained by our simple scoring method,
subintimal Ki-67+ cell density should prove useful as a powerful
but easy-to-use synovial marker for a variety of questions. By
extension, other constitutively nuclear proteins, such as many
transcription factors, will likely possess similar practical
advantages and may also turn out to be useful synovial
biomarkers.
Figure 4 Subintimal Ki-67+ and CD68+ cell densities correlate
positively with the histological degree of synovitis. The severity of
histological changes was graded in hematoxylin and eosin stained
sections (n = 37; 14 rheumatoid arthritis (RA), 10 osteoarthritis (OA), 5
orthopaedically-treated arthropathies (OrthA), and 8 normal) from 0–3 in
three parameters (lining thickness, stromal activation, inflammatory
infiltrates), the maximum score being 9. Consistent with previous
validations of this grading system,14 15 the mean (SEM) scores classified
the specimen groups as follows: RA, 5.8 (0.4) (score 4–6, ‘‘moderate
synovitis’’) OA, 2.2 (0.4) (score 2–4, ‘‘mild synovitis’’), and normal
controls, 1.5 (0.2) (score ,2, ‘‘no synovitis’’). Correlations were
determined by linear regression.
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